Westminster Homecare has been acquired by Care at Home
The private shareholders of Westminster Homecare Ltd. have sold the company to Care at Home Services (South East) Ltd.
Westminster Homecare is a specialist provider of care services to the elderly and young adults. It operates a network of branches throughout London and the South of England delivering care services to over 3,500 service users, enabling them to remain independent in their homes for longer.
Care at Home is a privately owned, independent family business providing a range of care services to clients in their own homes, under several brands including Care at Home Services, Beech Tree Total Care, Domus Live-In Care, and now Westminster Homecare. Care at Home partnered with ThinCats, an alternative lender that provides loans to mid-sized UK businesses, to help fund the transaction.
Oaklins Evelyn Partners, based in the UK, worked with the shareholders of Westminster Homecare to deliver a successful sale to a strategic partner. Combined, the group will be one of the largest providers of homecare services, with over 3,700 staff operating from 28 branches delivering homecare to the community and also care in 18 extra care facilities.
![](/api/deal-hero-image/106593/deal-hero-image.jpg)
![](/api/deal-party-images/106593/deal-parties.png)
![](/api/deal-client-photo/106593/deal-client-photo.jpg)
Sushil Radia
CEO, Westminster Homecare Ltd.
Talk to the deal team
Brian Livingston
Oaklins Evelyn Partners
Related deals
Leika Medical Equipments Ltd. has been acquired by Angus Capital
The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.
Learn morePhen’X Technologies has sold a majority stake to Ciclad
The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.
Learn moreMedis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments
Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).
Learn more